Sympathetically mediated changes in capacitance redistribution of the venous reservoir as a cause of decompensation

Circulation: Heart Failure

Volumn 4, Issue 5, 2011, Pages 669-675

  Fallick, Catherine ^a   Sobotka, Paul A ^b,c   Dunlap, Mark E ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c MEDTRONIC INC   (United States)

Author keywords

Autonomic nervous system; Blood volume; Fluid shifts; Heart failure; Splanchnic circulation; Sympathectomy; Veins

Indexed keywords

SODIUM; TOLVAPTAN;

ACUTE HEART FAILURE; ADRENERGIC SYSTEM; ARTICLE; BLOOD VESSEL CAPACITANCE; BLOOD VOLUME; EXTRACELLULAR FLUID; HUMAN; KIDNEY DYSFUNCTION; LUNG ARTERY PRESSURE; NONHUMAN; PRIORITY JOURNAL; SODIUM RETENTION; SPLANCHNIC BLOOD FLOW; VEIN BLOOD FLOW; VEIN DECOMPENSATION; VEIN DISEASE; WEIGHT GAIN; CASE REPORT; CORONARY BLOOD VESSEL; FEMALE; HEART FAILURE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

BLOOD VOLUME; CORONARY VESSELS; FEMALE; HEART FAILURE; HUMANS; MIDDLE AGED; SPLANCHNIC CIRCULATION; SYMPATHETIC NERVOUS SYSTEM; VASCULAR CAPACITANCE; WEIGHT GAIN;

EID: 80054947580     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.111.961789     Document Type: Article

References (73)

1. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418-1428.
2. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update incorporated into the acc/aha 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with The International Society for Heart and Lung Transplantation. Circulation. 2009;119:e391-e479.
3. Schiff GD, Fung S, Speroff T, McNutt RA. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med. 2003;114:625-630. (Pubitemid 36703230)
4. Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM. Patterns of weight change preceding hospitalization for heart failure. Circulation. 2007;116:1549-1554. (Pubitemid 47511418)
5. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF Study. J Am Coll Cardiol. 2008;51:1073-1079. (Pubitemid 351374766)
6. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658-666.
7. Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, Walton A, Adamson P, Kar S, Shah PK, Richards M, Eigler NL, Whiting JS, Haas GJ, Heywood JT, Frampton CM, Abraham WT. Physiciandirected patient self-management of left atrial pressure in advanced chronic heart failure. Circulation. 2010;121:1086-1095.
8. Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, Aaron MF, Aranda JM Jr, Abraham WT, Smart FW, Stevenson LW, Kueffer FJ, Bourge RC. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation. 2008;118:1433-1441.
9. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49:675-683. (Pubitemid 46205043)
10. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the Everest Outcome Trial. JAMA. 2007;297:1319-1331. (Pubitemid 46513233)
11. Pang PS, Konstam MA, Krasa HB, Swedberg K, Zannad F, Blair JE, Zimmer C, Teerlink JR, Maggioni AP, Burnett JC Jr, Grinfeld L, Ouyang J, Udelson JE, Gheorghiade M. Effects of tolvaptan on dyspnoea relief from the Everest trials. Eur Heart J. 2009;30:2233-2240.
12. Abraham WT, Compton S, Haas G, Foreman B, Canby RC, Fishel R, McRae S, Toledo GB, Sarkar S, Hettrick DA. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of The Fluid Accumulation Status Trial (FAST). Congest Heart Fail. 2011;17:51-55.
13. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:884-888. (Pubitemid 19046417)
14. Clark AL, Galloway S, MacFarlane N, Henderson E, Aitchison T, McMurray JJ. Catecholamines contribute to exertional dyspnoea and to the ventilatory response to exercise in normal humans. Eur Heart J. 1997;18:1829-1833. (Pubitemid 27477934)
15. Chapleau MW. Arterial baroreflexes. In: Izzo JL, Sica DA, Black HR, Council for High Blood Pressure Research (American Heart Association), eds. Hypertension Primer: [the Essentials of High Blood Pressure: Basic Science, Population Science, and Clinical Management]. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:120-123.
16. Dunlap ME. Cardiopulmonary baroreflexes. In: Izzo JL, Sica DA, Black HR, Council for High Blood Pressure Research (American Heart Association), eds. Hypertension Primer: [the Essentials of High Blood Pressure: Basic Science, Population Science, and Clinical Management]. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:123-125.
17. Gelman S. Venous function and central venous pressure: a physiologic story. Anesthesiology. 2008;108:735-748. (Pubitemid 351440595)
18. Birch DJ, Turmaine M, Boulos PB, Burnstock G. Sympathetic innervation of human mesenteric artery and vein. J Vasc Res. 2008;45:323-332. (Pubitemid 351793735)
19. Racchi H, Schliem AJ, Donoso MV, Rahmer A, Zuniga A, Guzman S, Rudolf K, Huidobro-Toro JP. Neuropeptide y y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation. Eur J Pharmacol. 1997;329:79-83. (Pubitemid 27264861)
20. King AJ, Osborn JW, Fink GD. Splanchnic circulation is a critical neural target in angiotensin ii salt hypertension in rats. Hypertension. 2007;50:547-556. (Pubitemid 47312243)
21. Gelman S, Mushlin PS. Catecholamine-induced changes in the splanchnic circulation affecting systemic hemodynamics. Anesthesiology. 2004;100:434-439. (Pubitemid 38133714)
22. Rothe CF. Mean circulatory filling pressure: its meaning and measurement. J Appl Physiol. 1993;74:499-509. (Pubitemid 23078136)
23. Fink GD, Arthur C. Corcoran Memorial Lecture: Sympathetic activity, vascular capacitance, and long-term regulation of arterial pressure. Hypertension. 2009;53:307-312.
24. Guyton AC, Coleman TG, Cowley AW Jr, Liard JF, Norman RA, Jr, Manning RD Jr. Systems analysis of arterial pressure regulation and hypertension. Ann Biomed Eng. 1972;1:254-281.
25. Burkhoff D, Tyberg JV. Why does pulmonary venous pressure rise after onset of LV dysfunction: a theoretical analysis. Am J Physiol. 1993;265:H1819-H1828. (Pubitemid 23348219)
26. Magder S, Veerassamy S, Bates JH. A further analysis of why pulmonary venous pressure rises after the onset of LV dysfunction. J Appl Physiol. 2009;106:81-90.
27. Balmain S, Padmanabhan N, Ferrell WR, Morton JJ, McMurray JJ. Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function. Eur J Heart Fail. 2007;9:865-871. (Pubitemid 47332319)
28. Nightingale AK, Blackman DJ, Ellis GR, Schmitt M, Morris-Thurgood JA, Jones EA, Frenneaux MP. Preservation of venous endothelial function in the forearm venous capacitance bed of patients with chronic heart failure despite arterial endothelial dysfunction. J Am Coll Cardiol. 2001;37:1062-1068. (Pubitemid 32217607)
29. Gunaruwan P, Maher A, Williams L, Sharman J, Schmitt M, Campbell R, Frenneaux M. Effects of bradykinin on venous capacitance in health and treated chronic heart failure. Clin Sci (Lond). 2009;116:443-450.
30. Adamson PB, Smith AL, Abraham WT, Kleckner KJ, Stadler RW, Shih A, Rhodes MM. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation. 2004;110:2389-2394. (Pubitemid 39407344)
31. Verrier RL, Tan A. Heart rate, autonomic markers, and cardiac mortality. Heart Rhythm. 2009;6:S68-S75.
32. Dibner-Dunlap ME, Thames MD. Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial baroreceptor sensitivity. Circ Res. 1989;65:1526-1535. (Pubitemid 20023548)
33. Sopher SM, Smith ML, Eckberg DL, Fritsch JM, Dibner-Dunlap ME. Autonomic pathophysiology in heart failure: carotid baroreceptor-cardiac reflexes. Am J Physiol. 1990;259:H689-H696. (Pubitemid 20310470)
34. Dibner-Dunlap ME, Thames MD. Control of sympathetic nerve activity by vagal mechanoreflexes is blunted in heart failure. Circulation. 1992;86:1929-1934.
35. Thames MD, Kinugawa T, Smith ML, Dibner-Dunlap ME. Abnormalities of baroreflex control in heart failure. J Am Coll Cardiol. 1993;22:56A-60A. (Pubitemid 23285798)
36. Kinugawa T, Dibner-Dunlap ME. Altered vagal and sympathetic control of heart rate in left ventricular dysfunction and heart failure. Am J Physiol. 1995;268:R317-R323.
37. Moore JP, Hainsworth R, Drinkhill MJ. Phasic negative intrathoracic pressures enhance the vascular responses to stimulation of pulmonary arterial baroreceptors in closed-chest anaesthetized dogs. J Physiol. 2004;555:815-824. (Pubitemid 38404600)
38. Zile MR, Adamson PB, Cho YK, Bennett TD, Bourge RC, Aaron MF, Aranda JM Jr, Abraham WT, Stevenson LW, Kueffer FJ. Hemodynamic factors associated with acute decompensated heart failure, part 1: insights into pathophysiology. J Card Fail. 2011;17:282-291.
39. Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M. Fluid overload in acute heart failure: re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail. 2008;10:165-169. (Pubitemid 351222743)
40. Ammons WS, Koyama S, Manning JW. Neural and vascular interaction in renin response to graded renal nerve stimulation. Am J Physiol. 1982;242:R552-R562. (Pubitemid 12099158)
41. Firth JD, Raine AE, Ledingham JG. Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet. 1988;1:1033-1035.
42. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53:589-596.
43. Verbalis JG. Body water osmolality. In: Wilkinson B JR, ed. Textbook of Nephrology. London: Chapman & Hall; 1997:89-94.
44. Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure: SOLVD Investigators. Circulation. 1992;86:431-438.
45. Goldstein S, Hjalmarson A. The mortality effect of metoprolol cr/xl in patients with heart failure: results of the MERIT-HF trial. Clin Cardiol. 1999;22(Suppl 5): V30-V35. (Pubitemid 29466573)
46. Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Staiger C, Holcslaw TL, Amann-Zalan I, De Mets DL. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106:2194-2199. (Pubitemid 35222212)
47. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11-21.
48. Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351:2049-2057.
49. Breithardt G. MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure. Eur Heart J. 2009;30:2551-2553.
50. Rousseau MF, Gurne O, Duprez D, Van Mieghem W, Robert A, Ahn S, Galanti L, Ketelslegers JM. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES Neurohormonal Substudy. J Am Coll Cardiol. 2002;40:1596-1601. (Pubitemid 35253637)
51. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A. Plasma norepinephrine, plasma renin activity, and congestive heart failure: relations to survival and the effects of therapy in V-Heft II: the V-Heft VA cooperative studies group. Circulation. 1993;87:VI40-VI48. (Pubitemid 23164221)
52. Hainsworth R. Vascular capacitance: its control and importance. Rev Physiol Biochem Pharmacol. 1986;105:101-173.
53. Kinugawa T, Dibner-Dunlap ME, Sica DA, Thames MD. Treatment with enalapril fails to prevent impaired cardiopulmonary baroreflex control in dogs with left ventricular dysfunction. J Card Fail. 1995;1:381-389.
54. Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Bohm M, Boll H, Baumann G, Honold M, Koehler K, Gelbrich G, Kirwan BA, Anker SD. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the Telemedical Interventional Monitoring in Heart Failure Study. Circulation. 2011;123:1873-1880.
55. Hara N, Iwasa M, Iwata K, Miyachi H, Tanaka H, Takeo M, Fujita N, Kobayashi Y, Takei Y. Value of the extracellular water ratio for assessment of cirrhotic patients with and without ascites. Hepatol Res. 2009;39:1072-1079.
56. Ring-Larsen H, Henriksen JH, Wilken C, Clausen J, Pals H, Christensen NJ. Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. BMJ (Clin Res Ed). 1986;292:1351-1353. (Pubitemid 16081812)
57. Culbertson JW, Wilkins RW, Ingelfinger FJ, Bradley SE. The effect of the upright posture upon hepatic blood flow in normotensive and hypertensive subjects. J Clin Invest. 1951;30:305-311.
58. Khouzam RN, Nelson MD, Klemis JE, Wall BM, Mangold TA, Weber KT. Effect of timed semirecumbency and furosemide dosing on urinary sodium excretion in patients with compensated heart failure. Am J Med Sci. 2006;332:1-5. (Pubitemid 44086657)
59. Abildgaard U, Aldershvile J, Ring-Larsen H, Falk J, Christensen NJ, Giese J, Hammer M, Henriksen JH. Bed rest and increased diuretic treatment in chronic congestive heart failure. Eur Heart J. 1985;6:1040-1046. (Pubitemid 16172533)
60. Packer M, Medina N, Yushak M. Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure. Circulation. 1985;71:761-766. (Pubitemid 15099127)
61. On bedresting in heart failure. Lancet. 1990;336:975-976.
62. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362:7-13. (Pubitemid 36835815)
63. Broqvist M, Dahlstrom U, Karlberg BE, Karlsson E, Marklund T. Neuroendocrine response in acute heart failure and the influence of treatment. Eur Heart J. 1989;10:1075-1083. (Pubitemid 20031948)
64. Missouris CG, Grouzmann E, Buckley MG, Barron J, MacGregor GA, Singer DR. How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide y and catecholamines. Clin Sci (Lond). 1998;94:591-599. (Pubitemid 28269058)
65. Marenzi G, Lauri G, Assanelli E, Grazi M, Campodonico J, Famoso G, Agostoni P. Serum to urinary sodium concentration ratio is an estimate of plasma renin activity in congestive heart failure. Eur J Heart Fail. 2002;4:597-603. (Pubitemid 35278512)
66. Stramba-Badiale M, Vanoli E, De Ferrari GM, Cerati D, Foreman RD, Schwartz PJ. Sympathetic-parasympathetic interaction and accentuated antagonism in conscious dogs. Am J Physiol. 1991;260:H335-H340.
67. Boulanger CM, Heymes C, Benessiano J, Geske RS, Levy BI, Vanhoutte PM. Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. Circ Res. 1998;83:1271-1278. (Pubitemid 29006042)
68. Van Wagoner DR. Chronic vagal nerve stimulation for the treatment of human heart failure: progress in translating a vision into reality. Eur Heart J. 2011;32:788-790.
69. Hauptman PJ, Mann DL. The vagus nerve and autonomic imbalance in heart failure: past, present, and future. Heart Fail Rev. 2011;16:97-99.
70. Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS. Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation. 2008;118:863-871.
71. Nozawa T, Igawa A, Fujii N, Kato B, Yoshida N, Asanoi H, Inoue H. Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats. Heart Vessels. 2002;16:51-56. (Pubitemid 34110714)
72. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-1909.
73. Investigators, Symplicity HTN-1. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57:911-917.